Contact this trialFirst, we need to learn more about you.
Small Molecule Inhibitor
KRT-232 +1 More for Polycythemia Vera
Recruiting2 awardsPhase 2
Canton, Ohio
This trial is testing a new drug, KRT-232, to treat patients with PV who can't take hydroxyurea or who have tried interferon. The trial has 2 parts. In the first part, patients will be given different doses and schedules of KRT-232. In the second part, patients will be given KRT-232 or ruxolitinib.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.